FAKTOR-OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Deutsche Boerse AG 20:49:22 24/05/2024 BST | ||
| 6.55 EUR | +0.46% |
|
| Current month | +8.44% | ||
| 1 month | -10.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 6.55 | +0.46% |
| 23/05/24 | 6.52 | -12.13% |
| 22/05/24 | 7.42 | +0.13% |
| 21/05/24 | 7.41 | +4.07% |
| 20/05/24 | 7.12 | +2.01% |
Delayed Quote Deutsche Boerse AG
Last update May 24, 2024 at 08:49 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV12D8 |
| ISIN | DE000SV12D89 |
| Date issued | 15/03/2023 |
| Strike | 76.77 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.08 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.82 € |
|---|---|
| Lowest since issue | 2.29 € |
| Spread | 0.03 € |
| Spread % | 0.45% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.98
USD
Average target price
96.16
USD
Spread / Average Target
+9.30%
- Stock Market
- Certificates
- Certificat
